Loh Y P, Gainer H
Endocrinology. 1979 Aug;105(2):474-87. doi: 10.1210/endo-105-2-474.
The neurointermediate lobes of dark adapted toads, Xenopus laevis, were incubated for 30 min in [3H]arginine, [3H]arginine plus [14C]glucosamine, or [3H]glucosamine and then chased for various time periods ranging from 1--3 h. The labeled polypeptides synthesized and secreted by the lobes were analyzed by acid-urea polyacrylamide gel electrophoresis. A glycosylated ACTH-endorphin precursor (32,000 mol wt) was synthesized during the pulse and identified by immunoprecipitation by ACTH-(11--24) antiserum. During the chase, this precursor was processed to various glycopeptides and peptides, including ACTH, beta-lipotropin, and alpha-MSH, which were subsequently secreted into the medium. An immunoprecipitable ACTH-related glycoprotein (approximately 150,000 mol wt) and other nonimmunoprecipitable glycoproteins (approximately 80,000--100,000 mol wt) were also synthesized and secreted by the neurointermediate lobe. The secretion of these glycoproteins and peptides was inhibited by dopamine. The significance of glycosylation of the precursor for the biosynthesis, processing, and secretion of the ACTH, beta-lipotropin-, and MSH-related peptides was examined by using a specific inhibitor of glycosylation, tunicamycin. Tunicamycin treatment did not affect the synthesis of the 32,000 mol wt ACTH-endorphin precursor but did prevent its glycosylation. The absence of carbohydrate on the precursor resulted in its rapid intracellular degradation. Precursors that escaped degradation were processed incompletely, leading to the formation and secretion of an unglycosylated intermediate and various other abnormal peptides. The data indicate that glycosylation of the ACTH-endorphin precursor may not be involved in the processes of intracellular transport, packaging, and secretion per se but, rather, may provide specific conformational stability to the precursor as a signal for directed limited proteolysis.
将暗适应的非洲爪蟾(Xenopus laevis)的神经中间叶在[3H]精氨酸、[3H]精氨酸加[14C]葡糖胺或[3H]葡糖胺中孵育30分钟,然后进行1至3小时的不同时长追踪。通过酸性尿素聚丙烯酰胺凝胶电泳分析叶合成和分泌的标记多肽。在脉冲期间合成了一种糖基化促肾上腺皮质激素 - 内啡肽前体(分子量32,000),并通过促肾上腺皮质激素 -(11 - 24)抗血清免疫沉淀鉴定。在追踪期间,该前体被加工成各种糖肽和肽,包括促肾上腺皮质激素、β - 促脂素和α - 促黑素,随后分泌到培养基中。神经中间叶还合成并分泌了一种可免疫沉淀的促肾上腺皮质激素相关糖蛋白(约150,000分子量)和其他不可免疫沉淀的糖蛋白(约80,000 - 100,000分子量)。多巴胺抑制了这些糖蛋白和肽的分泌。通过使用糖基化特异性抑制剂衣霉素,研究了前体糖基化对促肾上腺皮质激素、β - 促脂素和促黑素相关肽的生物合成、加工和分泌的意义。衣霉素处理不影响32,000分子量促肾上腺皮质激素 - 内啡肽前体的合成,但确实阻止了其糖基化。前体上缺乏碳水化合物导致其在细胞内快速降解。未降解的前体加工不完全,导致形成并分泌未糖基化的中间体和各种其他异常肽。数据表明,促肾上腺皮质激素 - 内啡肽前体的糖基化可能不参与细胞内运输、包装和分泌本身的过程,而是可能为前体提供特定的构象稳定性,作为定向有限蛋白水解的信号。